The output of Basic Pharmaceutical Products and Pharmaceutical Preparations in France has shown unusual stability from 2013 to 2021, maintaining a constant value. However, there was a sudden decrease in 2022 by -14.29%, with the output value dropping from 0.7 Units of Total to 0.6. This decline has continued to persist into 2023 and is expected to remain unchanged through 2028, with the projected CAGR at 0% for the coming years. The values show no year-on-year variation from 2023 to 2028.

Future trends to watch for:

Potential policy changes in the pharmaceutical sector could influence output levels.
Technological advancements might lead to increased efficiency and higher production capacities.
Market demand shifts due to aging populations or emerging health crises could alter production needs.